Harnessing the Effects of BTKi on T Cells for Effective Immunotherapy against CLL

por Mhibik, Maissa, Wiestner, Adrian, Sun, Clare
Publicado 2019

Severe renal Fanconi and management strategies in Arthrogryposis-Renal dysfunction-Cholestasis syndrome: a case report

por Rosales, Alejandra, Mhibik, Maissa, Gissen, Paul, Segarra, Oscar, Redecillas, Susana, Ariceta, Gema
Publicado 2018

Immuno-regulatory malignant B cells contribute to Chronic Lymphocytic Leukemia progression

por Mékinian, Arsène, Quinquenel, Anne, Belkacem, Koceïla Ait, Kanoun, Feriel, Dondi, Elisabetta, Franck, Emilie, Boubaya, Marouane, Mhibik, Maïssa, Baran-Marszak, Fanny, Letestu, Rémi, Ajchenbaum-Cymbalista, Florence, Lévy, Vincent, Varin-Blank, Nadine, Le Roy, Christine
Publicado 2023

Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia

por Cyr, Matthew G, Mhibik, Maissa, Qi, Junpeng, Peng, Haiyong, Chang, Jing, Gaglione, Erika M, Eik, David, Herrick, John, Venables, Thomas, Novick, Scott J, Courouble, Valentine V, Griffin, Patrick R, Wiestner, Adrian, Rader, Christoph
Publicado 2022

Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting

por Mhibik, Maissa, Gaglione, Erika M., Eik, David, Herrick, John, Le, Janet, Ahn, Inhye E., Chiu, Christopher, Wielgos-Bonvallet, Monica, Hiemstra, Ida H., Breij, Esther C. W., Chen, Jenny, Reilly, Edward B., Epling-Burnette, Pearlie K., Szafer-Glusman, Edith, Sun, Clare, Wiestner, Adrian
Publicado 2023